ARCHIVES

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Concept For New $850,000 Year Grant Program To Study Viruses In Cervical Cancer

November 9, 1984

IOM: No Negligence In FIAU Clinical Trial That Killed Five

March 31, 1995

Foundations Invites Antitobacco Proposals

October 15, 1993

Clinical Trials Approved by NCI CTEP Last Month

August 26, 2011

In Brief: NCI Gets $937 Million For FY 79 As Congress Adjourns; Cancer Act Renewed For Two Years

October 20, 1978

WHI Update: No Increased Risk Of Cancer With Estrogen-Alone

April 28, 2006